[{"id":"3c4b70e5-0095-4941-b867-c448ada0131d","acronym":"","url":"https://clinicaltrials.gov/study/NCT05879250","created_at":"2023-05-30T14:05:05.692Z","updated_at":"2024-07-02T16:34:59.705Z","phase":"Phase 2","brief_title":"WP1066 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma","source_id_and_acronym":"NCT05879250","lead_sponsor":"Northwestern University","biomarkers":" IDH1 • MGMT","pipe":" | ","alterations":" RAS wild-type • IDH wild-type","tags":["IDH1 • MGMT"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e RAS wild-type • IDH wild-type"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e WP1066"],"overall_status":"Recruiting","enrollment":" Enrollment 39","initiation":"Initiation: 05/22/2024","start_date":" 05/22/2024","primary_txt":" Primary completion: 12/27/2027","primary_completion_date":" 12/27/2027","study_txt":" Completion: 12/27/2028","study_completion_date":" 12/27/2028","last_update_posted":"2024-05-31"},{"id":"4992c086-2aab-4254-878a-7ce1b1e555fb","acronym":"","url":"https://clinicaltrials.gov/study/NCT04334863","created_at":"2021-01-18T20:59:17.912Z","updated_at":"2024-07-02T16:35:55.122Z","phase":"Phase 1","brief_title":"WP1066 in Children With Refractory and Progressive or Recurrent Malignant Brain Tumors","source_id_and_acronym":"NCT04334863","lead_sponsor":"Emory University","biomarkers":" STAT3","pipe":"","alterations":" ","tags":["STAT3"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e WP1066"],"overall_status":"Completed","enrollment":" Enrollment 10","initiation":"Initiation: 05/04/2020","start_date":" 05/04/2020","primary_txt":" Primary completion: 02/03/2023","primary_completion_date":" 02/03/2023","study_txt":" Completion: 02/03/2023","study_completion_date":" 02/03/2023","last_update_posted":"2023-02-21"},{"id":"54accd08-1a26-4357-b09a-9c2d8e7f781a","acronym":"","url":"https://clinicaltrials.gov/study/NCT01904123","created_at":"2021-01-18T08:34:31.425Z","updated_at":"2024-07-02T16:36:14.851Z","phase":"Phase 1","brief_title":"STAT3 Inhibitor WP1066 in Treating Patients With Recurrent Malignant Glioma or Progressive Metastatic Melanoma in the Brain","source_id_and_acronym":"NCT01904123","lead_sponsor":"M.D. Anderson Cancer Center","biomarkers":" BRAF","pipe":" | ","alterations":" BRAF positive","tags":["BRAF"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BRAF positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e WP1066"],"overall_status":"Completed","enrollment":" Enrollment 8","initiation":"Initiation: 07/13/2018","start_date":" 07/13/2018","primary_txt":" Primary completion: 03/16/2022","primary_completion_date":" 03/16/2022","study_txt":" Completion: 03/16/2022","study_completion_date":" 03/16/2022","last_update_posted":"2022-03-23"}]